Siegmund Karasch
Director/Board Member at DEUTSCHE BIOTECH INNOVATIV AG
Profile
Siegmund Karasch is the founder of AdrenoMed AG.
He is currently a Member-Supervisory Board at Deutsche Biotech Innovativ AG since 2018.
Previously, he worked as Chief Executive & Operating Officer at InVivo BioTech Services GmbH.
He completed his undergraduate degree from Hochschule für Technik und Wirtschaft Berlin in 1993.
Siegmund Karasch active positions
| Companies | Position | Start |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Director/Board Member | 2018-07-04 |
Former positions of Siegmund Karasch
| Companies | Position | End |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Founder | 2013-12-31 |
InVivo BioTech Services GmbH
 InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Chief Executive Officer | - |
Training of Siegmund Karasch
| Hochschule für Technik und Wirtschaft Berlin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Finance |
| Private companies | 2 |
|---|---|
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Siegmund Karasch
